Durability of Effect With Long-Term Droxidopa Treatment in Patients with Symptomatic Neurogenic Orthostatic Hypotension

被引:0
|
作者
Isaacson, Stuart [3 ]
Lisk, Jerome [4 ]
Liang, Grace [2 ]
Rowse, Gerald [1 ]
机构
[1] Lundbeck NA Ltd, Charlotte, NC USA
[2] Neurocrine Biosci Inc, San Diego, CA USA
[3] Parkinsons Dis & Movement Disorders Ctr Boca Rato, Boca Raton, FL USA
[4] Southern Calif Movement Disorder Specialists, Pasadena, CA USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P5.128
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension
    Isaacson, Stuart
    Vernino, Steven
    Ziemann, Adam
    Rowse, Gerald J.
    Kalu, Uwa
    White, William B.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2016, 10 (10) : 755 - 762
  • [2] Durability of effect with long-term, open-label droxidopa treatment in patients with symptomatic neurogenic orthostatic hypotension (NOH 303)
    Isaacson, S.
    Shill, H.
    Vernino, S.
    Cioffi, C.
    Hutchman, R.
    [J]. MOVEMENT DISORDERS, 2012, 27 : S424 - S425
  • [3] Use of droxidopa for the long-term treatment of neurogenic orthostatic hypotension
    Raj, Satish R.
    Hewitt, Lawrence Arthur
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 (01) : 69 - 70
  • [4] Safety and Durability of Effect with Long-Term, Open-Label Droxidopa Treatment in Patients with Symptomatic Neurogenic Orthostatic Hypotension (NOH303)
    Isaacson, Stuart
    Shill, Holly A.
    Vernino, Steven
    Ziemann, Adam
    Rowse, Gerald J.
    [J]. JOURNAL OF PARKINSONS DISEASE, 2016, 6 (04) : 751 - 759
  • [5] Use of droxidopa for the long-term treatment of neurogenic orthostatic hypotension Reply
    Brignole, Michele
    Fanciulli, Alessandra
    van Dijk, Gert
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 (01) : 71 - 71
  • [6] Durability of effect with long-term droxidopa treatment in patients with symptomatic NOH
    Isaacson, S.
    Liang, G.
    Lisk, J. P.
    [J]. MOVEMENT DISORDERS, 2015, 30 : S93 - S93
  • [7] Responder analyses of droxidopa in patients with symptomatic neurogenic orthostatic hypotension
    Rowse, G. J.
    Hewitt, L. A.
    Shields, A.
    Freeman, R.
    Kaufmann, H.
    [J]. MOVEMENT DISORDERS, 2015, 30 : S116 - S117
  • [8] Responder Analyses of Droxidopa in Patients with Symptomatic Neurogenic Orthostatic Hypotension
    Rowse, Gerald
    Hewitt, Lawrence
    Shields, Alan
    Freeman, Roy
    Kaufmann, Horacio
    [J]. NEUROLOGY, 2016, 86
  • [9] Cardiovascular Safety of Droxidopa in Patients With Symptomatic Neurogenic Orthostatic Hypotension
    White, William B.
    Hauser, Robert A.
    Rowse, Gerald J.
    Ziemann, Adam
    Hewitt, L. Arthur
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2017, 119 (07): : 1111 - 1115
  • [10] Long-term Efficacy Of Atomoxetine For The Treatment Of Symptomatic Neurogenic Orthostatic Hypotension
    Urechie, Vasile
    Rigo, Stefano
    Palma, Jose-Alberto
    Diedrich, Andre
    Biaggioni, Italo
    Kaufmann, Horacio
    Shibao, Cyndya A.
    [J]. HYPERTENSION, 2022, 79